Search results
ICON has announced it has entered into a definitive agreement to acquire PRA Health Sciences, Inc to create a world leading healthcare intelligence and clinical CRO.
Feb 24, 2021 · PRA’s mobile and connected health platforms and real world data and information solutions together with ICON’s Accellacare site network, home health services and wearables expertise, will be combined to deliver differentiated decentralised and hybrid trial solutions to meet growing customer needs.
PRA Health Sciences was a contract research organization (CRO) with headquarters in Raleigh, North Carolina. It was established in 1976 and acquired by ICON in 2021.
Jul 1, 2021 · Dublin, Ireland, 1st July 2021 – ICON plc, (NASDAQ: ICLR) today announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and clinical research organisation.
Jul 1, 2021 · ICON plc, a global healthcare intelligence and clinical research organisation, completes its acquisition of PRA Health Sciences, creating a world-leading company with 38,000 employees. The combined company will leverage data, technology and patient populations to transform clinical trials and accelerate biopharma customers' success.
PRA Health Sciences is a research services company that offers clinical development, product registration, and data and technology solutions. It is now part of ICON plc, a global healthcare intelligence and clinical research organisation.
Feb 25, 2021 · hares of PRA Health Sciences jumped nearly 18.7% on Feb. 24 after the research company inked a deal with ICON plc to be acquired in a cash-and-stock deal worth $12 billion.
